In vivo ubiquitination assays revealed a significant reduction in GLI1-linked polyubiquitin chains in GBM cells overexpressing USP28, whereas such chains were scarcely detectable in USP28 S67A point mutants (Figure 5K-L and Figure S8D). The gene discussed is GLI1; the disease is glioblastoma.